BRPI0716548A2 - bacterinas tratadas termicamente e vacinas em emulsço preparadas de tais bacterinas tratadas termicamente - Google Patents

bacterinas tratadas termicamente e vacinas em emulsço preparadas de tais bacterinas tratadas termicamente

Info

Publication number
BRPI0716548A2
BRPI0716548A2 BRPI0716548-0A2A BRPI0716548A BRPI0716548A2 BR PI0716548 A2 BRPI0716548 A2 BR PI0716548A2 BR PI0716548 A BRPI0716548 A BR PI0716548A BR PI0716548 A2 BRPI0716548 A2 BR PI0716548A2
Authority
BR
Brazil
Prior art keywords
heat treated
treated bacterins
bacterins
vaccines prepared
emulsion vaccines
Prior art date
Application number
BRPI0716548-0A2A
Other languages
English (en)
Inventor
Mark Davis Goodyear
Michael John Huether
Ramasamy Mannar Mannan
Nancee Lois Oien
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BRPI0716548A2 publication Critical patent/BRPI0716548A2/pt
Publication of BRPI0716548B1 publication Critical patent/BRPI0716548B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BRPI0716548-0A 2006-09-11 2007-08-30 Vacina em emulsão, seu método de produção e método para preparação de uma bacterina leptospira tratada termicamente da vacina em emulsão BRPI0716548B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84366506P 2006-09-11 2006-09-11
US60/843,665 2006-09-11
PCT/IB2007/002553 WO2008032158A2 (en) 2006-09-11 2007-08-30 Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins

Publications (2)

Publication Number Publication Date
BRPI0716548A2 true BRPI0716548A2 (pt) 2013-09-24
BRPI0716548B1 BRPI0716548B1 (pt) 2020-10-06

Family

ID=39110574

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0716548-0A BRPI0716548B1 (pt) 2006-09-11 2007-08-30 Vacina em emulsão, seu método de produção e método para preparação de uma bacterina leptospira tratada termicamente da vacina em emulsão

Country Status (26)

Country Link
US (1) US8491915B2 (pt)
EP (2) EP2066340B1 (pt)
JP (2) JP5550341B2 (pt)
KR (1) KR101238486B1 (pt)
CN (1) CN101516393B (pt)
AR (1) AR062758A1 (pt)
AU (1) AU2007297287B2 (pt)
BR (1) BRPI0716548B1 (pt)
CA (1) CA2663166C (pt)
CL (1) CL2007002621A1 (pt)
CO (1) CO6160333A2 (pt)
DK (2) DK2066340T3 (pt)
ES (2) ES2535977T3 (pt)
ME (1) ME00598B (pt)
MX (1) MX2009001849A (pt)
NO (1) NO339147B1 (pt)
NZ (2) NZ595748A (pt)
PL (2) PL2377550T3 (pt)
PT (1) PT2066340E (pt)
RS (1) RS54981B1 (pt)
RU (2) RU2425692C2 (pt)
SI (1) SI2066340T1 (pt)
TW (1) TWI361077B (pt)
UA (1) UA98115C2 (pt)
WO (1) WO2008032158A2 (pt)
ZA (1) ZA200902493B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2224951T3 (da) 2007-12-21 2020-01-06 Zoetis Services Llc Varmebehandlede bakteriner og emulsionsvacciner, der er fremstillet af sådanne varmebehandlede bakteriner
EP2717055A1 (en) * 2012-10-04 2014-04-09 Institut Pasteur Use of Leptospira fainei serovar Hurstbridge bacteria for diagnosing leptospirosis
JP2024510057A (ja) * 2020-05-26 2024-03-06 サイラス トェンティファースト センチュリー アントレプレナーシップ エルエルシー ハキムプールシナの除染手順

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3721169A1 (de) * 1986-06-30 1988-01-14 Lion Corp Orale zubereitung
US5084269A (en) 1986-11-06 1992-01-28 Kullenberg Fred W Adjuvant for dose treatment with antigens
RU2030915C1 (ru) * 1990-10-31 1995-03-20 Всероссийский государственный научно-исследовательский институт контроля, стандартизации и сертификации ветеринарных препаратов Вакцина против лептоспироза животных
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof
AU2001234616A1 (en) 2000-01-31 2001-08-07 Vic Jira Vaccine composition, process and methods
US20030147914A1 (en) 2001-07-02 2003-08-07 Pfizer Inc. Mycoplasma bovis vaccine and methods of reducing pneumonia in animals
EA011578B1 (ru) 2002-08-26 2009-04-28 Пфайзер Продактс Инк. Иммуногенная композиция для защиты крупного рогатого скота от инфекций респираторной и репродуктивной систем и ее применение
WO2004026024A2 (en) 2002-09-20 2004-04-01 The United States Of America As Represented By The Secretary Of Agriculture Vaccine compositions and adjuvant
AU2002951692A0 (en) 2002-09-23 2002-10-17 Vital Biotech (Hong Kong) Limited Improvements in or relating to vaccines
RU2005124130A (ru) * 2003-01-29 2006-01-20 Пфайзер Продактс Инк. (Us) Вакцины для собак против bordetella bronchiseptica
RU2541809C2 (ru) * 2003-04-04 2015-02-20 Зоетис Пи ЛЛК Микрофлюидизированные эмульсии "масло в воде" и композиции вакцины

Also Published As

Publication number Publication date
CA2663166C (en) 2015-11-03
CA2663166A1 (en) 2008-03-20
JP5643906B2 (ja) 2014-12-17
EP2066340B1 (en) 2013-07-31
CL2007002621A1 (es) 2008-03-14
RU2569457C2 (ru) 2015-11-27
MX2009001849A (es) 2009-03-02
PL2066340T3 (pl) 2013-12-31
CN101516393B (zh) 2014-05-14
UA98115C2 (ru) 2012-04-25
CO6160333A2 (es) 2010-05-20
NO20090745L (no) 2009-03-11
KR20090039840A (ko) 2009-04-22
AU2007297287A1 (en) 2008-03-20
RU2011115400A (ru) 2012-10-27
SI2066340T1 (sl) 2013-11-29
ZA200902493B (en) 2010-03-31
TWI361077B (en) 2012-04-01
MEP7509A (en) 2011-12-20
ES2432392T3 (es) 2013-12-03
JP5550341B2 (ja) 2014-07-16
RS20090088A (sr) 2010-06-30
TW200820990A (en) 2008-05-16
EP2377550B1 (en) 2015-03-04
WO2008032158A3 (en) 2008-07-03
JP2010502238A (ja) 2010-01-28
EP2377550A1 (en) 2011-10-19
KR101238486B1 (ko) 2013-03-04
JP2014088428A (ja) 2014-05-15
RU2009108004A (ru) 2010-10-20
WO2008032158A2 (en) 2008-03-20
RS54981B1 (sr) 2016-11-30
PT2066340E (pt) 2013-10-30
AU2007297287B2 (en) 2013-03-14
CN101516393A (zh) 2009-08-26
PL2377550T3 (pl) 2015-07-31
US8491915B2 (en) 2013-07-23
DK2377550T3 (en) 2015-04-07
RU2425692C2 (ru) 2011-08-10
NZ574896A (en) 2011-11-25
EP2066340A2 (en) 2009-06-10
BRPI0716548B1 (pt) 2020-10-06
NO339147B1 (no) 2016-11-14
AR062758A1 (es) 2008-12-03
US20080112970A1 (en) 2008-05-15
ES2535977T3 (es) 2015-05-19
ME00598B (me) 2011-12-20
HK1130202A1 (en) 2009-12-24
DK2066340T3 (da) 2013-10-14
NZ595748A (en) 2013-07-26

Similar Documents

Publication Publication Date Title
BRPI0815196A2 (pt) aparelho e método de refrigeração
EP1871216A4 (en) THERMAL CAPSULOTOMY TOOL AND SYSTEM
EP2046213A4 (en) BONE FIXATION SYSTEM AND METHOD OF USE
BRPI0615559A2 (pt) sistema e método de autenticação de usúario de rede
DE602007008498D1 (de) Motorsteuervorrichtung und dazugehöriges Motorsteuerverfahren
ZA201005178B (en) Heat treated bacterins,and emulsion vaccines prepared from such heat treated bacterins
BRPI0813757A2 (pt) Sistema de implante, e, método
SE0702458L (sv) Styrsystem och -metod
DE112006001892A5 (de) Heizsystem
BRPI0717659A2 (pt) Método de alocação de sequência e aparelho de alocação de sequência
BRPI0811160A2 (pt) Aquecedor e método de operação
DE602007011682D1 (de) Radargerät und Radarverfahren
EP2013554A4 (en) DEVICE AND METHOD FOR CONTROLLING A REFRIGERATION SYSTEM
IL193643A (en) Metal heat treating methods and devices
DK1974592T3 (da) Kølesystem og -fremgangsmåde
IL190287A (en) Method of and system for controlling a kiln
DE602007000874D1 (de) Motorsteuervorrichtung und Motorsteuerverfahren
BRPI0807767A2 (pt) Sistema trocador de calor e método de operar o mesmo.
ITMI20060299A1 (it) Sistema per il trattamento di fumi
BRPI0603421A (pt) dispositivo supressor de infravermelho com abafador em peça única e método
FR2886388B1 (fr) Systeme de chauffage et de refrigeration
ITMI20061648A1 (it) Dispositivo di irraggiamento di calore tramite infrarossi
NO20076395L (no) Forbrenningssystem og -fremgangsmåte
PT2340328T (pt) Sistema e método para o tratamento do amianto
DE602006017692D1 (de) Wärmebehandlungsvorrichtung

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: PAH USA 15 LLC (US)

B25D Requested change of name of applicant approved

Owner name: ZOETIS P LLC (US)

B25A Requested transfer of rights approved

Owner name: ZOETIS SERVICES LLC (US)

B25G Requested change of headquarter approved

Owner name: ZOETIS SERVICES LLC (US)

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 06/10/2020, OBSERVADAS AS CONDICOES LEGAIS.